Zydus Cadila Launches Generic Version of Sofosbuvir in India under Brand Name ‘SoviHep’

March 18, 2015 9:22 PM

9 0

Today, drug firm Zydus Cadila has launched SoviHep, a generic version of Gilead Sciences' Hepatitis C drug Sofosbuvir, in India. A non-exclusive agreement between Zydus Cadila and Gilead Sciences will allow two things manufacturing and distribution.

As per the agreement, the manufacturing of sofosbuvir could be done and distribution of the fixed-dose combination of ledipasvir/sofosbuvir in 91 countries will also be permitted.

Also read: Will Political Reality Derail Markets’ Bet on Donald Trump?

Read more

To category page

Loading...